A multicenter, randomized, double-blind study on the effects of aripiprazole in overweight patients treated with olanzapine for schizophrenia or schizoaffective disorder.
Phase of Trial: Phase III
Latest Information Update: 08 Nov 2013
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions; Pharmacodynamics
- 05 Feb 2007 Status change
- 09 Oct 2005 New trial record.